Identification of a transactivation activity in the COOH-terminal region of p73 which is impaired in the naturally occurring mutants found in human neuroblastomas

Cancer Research

Volumn 59, Issue 12, 1999, Pages 2810-2814

  Takada, Naoyuki ^a,c   Ozaki, Toshinori ^a   Ichimiya, Shingo ^b   Todo, Satoru ^c   Nakagawara, Akira ^a  

^a CHIBA CANCER CENTER   (Japan)

^b SAPPORO MEDICAL UNIVERSITY   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CARCINOGENESIS; GENE MUTATION; HUMAN; HUMAN CELL; NEUROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

3' UNTRANSLATED REGIONS; ANIMALS; BETA-GALACTOSIDASE; COS CELLS; DNA-BINDING PROTEINS; ENZYME ACTIVATION; FUNGAL PROTEINS; GENES, TUMOR SUPPRESSOR; HELA CELLS; HUMANS; MUTATION, MISSENSE; NEUROBLASTOMA; NUCLEAR PROTEINS; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 0033564513     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Levine, A. J., Momand, J., and Finaly, C. A. The p53 tumour suppressor gene. Nature (Lond.), 351: 453-456, 1991.
2. Hollstein, M., Sidransky, D., Vogelstein, B., and Harris, C. C. p53 mutations in human cancers. Science (Washington DC), 253: 49-53, 1991.
3. Donehower, L. A., and Bradley, A. The tumor suppressor p53. Biochim. Biophys. Acta, 1155: 181-205, 1993.
4. Friend, S. A glimpse at the puppet behind the shadow play. Science (Washington DC), 265: 334-335, 1994.
5. Levine, A. J. The tumor suppressor genes. Annu. Rev. Biochem., 62: 623-651, 1993.
6. Gottlieb, T. M., and Oren, M. p53 in growth control and neoplasia. Biochim. Biophys. Acta, 1287: 77-102, 1996.
7. Ko, L. J., and Prives, C. p53 in growth control and neoplasia. Genes Dev., 10: 1054-1072, 1996.
8. Levine, A. J. p53, the cellular gatekeeper for growth and division. Cell, 88: 323-331, 1997.
9. Pientenpol, J. A., Tokino, T., Thiagalingam, S., El-Deiry, W. S., Kinzler, K. W., and Vogelstein, B. Sequence-specific transcriptional activation is essential for growth suppression by p53. Proc. Natl. Acad. Sci. USA, 91: 1998-2002, 1994.
10. Crook, T., Marston, N. J., Sara, E. A., and Vousden, K. H. Transcriptional activation by p53 correlates with suppression of growth but not transformation. Cell, 79: 817-827, 1994.
11. Ory, K., Legros, Y., Auguin, C., and Soussi, T. Analysis of the most representative tumour-derived p53 mutants reveals that changes in protein conformation are not correlated with loss of transactivation or inhibition of cell proliferation. EMBO J., 13: 3496-3504, 1994.
12. Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., and Fornace, A. J., Jr. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell, 71: 587-597, 1992.
13. Barak, Y. T., Juven, T., Haffner, R., and Oren, M. mdm2 expression is induced by wild type p53 activity. EMBO J., 12: 461-468, 1993.
14. Wu, X., Bayle, J. H., Olson, D., and Levine, A. J. The p53-mdm-2 autoregulatory feedback loop. Genes Dev., 7: 1126-1132, 1993.
15. El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parson, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression. Cell, 75: 817-825, 1993.
16. Okamoto, K., and Beach, D. Cyclin G is a transcriptional target of the p53 tumor suppressor protein. EMBO J., 13: 4816-4822, 1994.
17. Zauberman, A., Lupe, A., and Oren, M. Identification of p53 target genes through immune selection of genomic DNA: the cyclin G gene contains two distinct p53 binding sites. Oncogene, 10: 2361-2366, 1995.
18. Vermeh-Ziaie, S., Okan, I., Wang, Y., Magnusson, K. P., Warthoe, P., Strauss, M., and Wiman, K. G. Wig-1, a new p53-induced gene encoding a zinc finger protein. Oncogene, 15: 2699-2704, 1997.
19. Prives, C. How loops, β sheets, and a helices help us to understand p53. Cell, 78: 543-546, 1994.
20. Gu, W., and Roeder, R. G. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell, 90: 595-606, 1997.
21. Kaghad, M., Bonnet, H., Yang, A., Creancier, L., Biscan, J-C., Valent, A., Minty, A., Chalon, P., Lelias, J-M., Dumont, X., Ferrara, P., Mckeon, F., and Caput, D. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell, 90: 809-819, 1997.
22. Jost, C. A., Maria, M. C., and Kaelin, W. G., Jr. p73 is a human p53-related protein that can induce apoptosis. Nature (Lond.), 389: 191-194, 1997.
23. Ichimiya, S., Nimura, Y., Kageyama, H., Takada, N., Sunahara, M., Shishikura, T., Nakamura, Y., Sakiyama, S., Seki, N., Ohira, M., Kaneko, Y., Mckeon, F., Caput, D., and Nakagawara, A. p73 at chromosome 1p36.3 is lost in advanced stage neuroblastoma but its mutation is infrequent. Oncogene, 18: 1061-1066, 1999.
24. Monteiro, A. N. A., August, A., and Hanafusa, H. Evidence for a transcriptional activation function of BRCA1 C-terminal region. Proc. Natl. Acad. Sci. USA, 93: 13595-13599, 1996.
25. Ozaki, T., and Sakiyama, S. Identification of essential cis-acting regulatory elements for transcription of the rat DAN gene. DNA Cell Biol., 16: 779-786, 1997.
26. Courey, A. J., and Tjian, R. Analysis of Sp1 in vivo reveals multiple transcriptional domains, including a novel glutamine-rich activation motif. Cell, 55: 887-898, 1998.
27. Hope, I. A., and Strahl, K. Functional dissection of a eukaryotic transcriptional activator protein, GCN4 of yeast. Cell, 46: 885-894, 1986.
28. Mitchell, P. J., and Tjian, R. Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. Science (Washington DC), 245: 371-378, 1989.
29. Osada, M., Ohba, M., Kawahara, C., Ishioka, C., Kanamaru, R., Katoh, I., Ikawa, Y., Nimura, Y., Nakagawara, A., Obineta, M., and Ikawa, S. Cloning and functional analysis of human p51, which structurally and functionally resembles p53. Nat. Med., 4: 839-843, 1998.
30. Takahashi, H., Ichimiya, S., Watanabe, M., Furasato, M., Wakui, S., Yatani, R., Aizawa, S., and Nakagawara, A. Mutation, allelotyping, and transcription analyses of the p73 gene in prostatic carcinoma. Cancer Res., 58: 2076-2077, 1998.
31. Nomoto, S., Haruki, N., Kondo, M., Konishi, H., Takahashi, T., Takahashi, T., and Takahashi, T. Search for mutations and examination of allelic expression imbalance of the p73 gene at 1p36.33 in human lung cancers. Cancer Res., 58: 1380-1383, 1998.
32. Nimura, Y., Mihara, M., Ichimiya, S., Sakiyama, S., Seki, N., Ohira, M., Nomura, N., Fujimori, M., Adachi, W., Amano, J., He, M., Ping, Y-M., and Nakagawara, A. p73, a gene related to p53, is not mutated in esophageal carcinomas. Int. J. Cancer, 78: 437-440, 1998.
33. Mihara, M., Nimura, Y., Ichimiya, S., Sakiyama, S., Kajikawa, S., Adachi, W., Amano, J., and Nakagawara, A. Absence of mutation of the p73 gene localized at chromosome 1p36.3 in hepatocellular carcinoma. Br. J. Cancer, 79: 164-167, 1999.
34. Shishikura, T., Ichimiya, S., Ozaki, T., Nimura, Y., Kageyama, H., Nakamura, Y., Sakiyama, S., Miyauchi, M., Yamamoto, N., Suzuki, M., Nakajima, N., and Nakagawara, A. Mutational analysis of the p73 gene in human breast cancers. Int. J. Cancer, in press, 1999.
35. Sunahara, M., Shishikura, T., Takahashi, M., Todo, S., Yamamoto, N., Kimura, H., Kato, S., Ishioka, C., Ikawa, S., Ikawa, Y., and Nakagawara, A. Mutational analysis of p51A/TAp63γ, a p53 homolog, in non-small cell lung cancer and breast cancer. Oncogene, in press, 1999.
36. White, P. S., Maris, J. M., Beltinger, C., Sulman, E., Marshall, H. N., Fujimori, M., Kaufman, B. A., Biegel, J. A., Allen, C., Hilliard, C., Valentine, M. B., Look, A. T., Enomoto, H., Sakiyama, S., and Brodeur, G. M. A region of consistent deletion in neuroblastoma maps within 1p36.2-3. Proc. Natl. Acad. Sci. USA, 92: 5520-5524, 1995.
37. Schwab, M., Praml, C., and Amler, L. C. Genomic instability in 1p and human malignancies. Genes Chromosomes Cancer, 16: 211-229, 1996.
38. Momand, J., Zambetti, G. P., Olson, D. C., George, D. L., and Levine, A. J. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell, 69: 1237-1245, 1992.
39. Clurman, B., and Groudine, M. Tumour-suppressor genes. Killer in search of a motive? Nature (Lond.), 389: 122-123, 1997.